(Q36029111)

11 August 2017

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study (English)

1 reference

11 August 2017

1 reference

Coleman MP

1

1 reference

11 August 2017

Bell CM

series ordinal

2

1 reference

11 August 2017

Fraser P

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 1987

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

56

1 reference

11 August 2017

3

1 reference

11 August 2017

349-355

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1987.201

11 August 2017

0 references

cites work

Multiple primary cancers in Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Chemotherapy of Hodgkin's disease comes of age.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Risk of leukaemia associated with cancer chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Cohort study analysis with a FORTRAN computer program.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Bilateral testicular germ cell tumors. Report of nine cases and review of the literature.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Elementary methods of cohort analysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

National survey of patterns of care for Hodgkin's disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

The medical consequences of cure.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

The analysis of mortality by the subject-years method

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002200

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

23 September 2018

1 reference

12 December 2020

Further advances in the management of malignant teratomas of the testis and other sites

1 reference

12 December 2020

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

12 December 2020

Leukemia after cytotoxic chemotherapy--a pyrrhic victory?

1 reference

12 December 2020

Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience

1 reference

12 December 2020

Subsequent malignancies in patients irradiated for testicular tumours

1 reference

12 December 2020

Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis

1 reference

12 December 2020

Secondary non-hematopoietic cancers arising following treatment of hematopoietic disorders

1 reference

12 December 2020

Breast cancer in women after repeated fluoroscopic examinations of the chest

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1987.201

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference